• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Lactation elevated protein 1 (LACE1)

ACP14784

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP14784 Target NameAFG1L
Target SynonymsAFG1; ATPase family gene 1 homolog; CG8520 gene product; lace1; LACE1_HUMAN; Lactation elevated protein 1; Lactivation elevated 1; Protein AFG1 homologFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-481
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8WV93
Background Information
  • Uniprot Id

    Q8WV93

  • Target Species

    Human

  • Target Name

    AFG1L

  • Target Full Name

    AFG1-like ATPase

  • Target Function

    Putative mitochondrial ATPase. Plays a role in mitochondrial morphology and mitochondrial protein metabolism. Promotes degradation of excess nuclear-encoded complex IV subunits (COX4I1, COX5A and COX6A1) and normal activity of complexes III and IV of the respiratory chain. Mediates mitochondrial translocation of TP53 and its transcription-independent apoptosis in response to genotoxic stress.

  • Target Subcellular Location

    Mitochondrion membrane.

  • Target Protein Families

    AFG1 ATPase family

  • Target Synonyms

    AFG1; ATPase family gene 1 homolog; CG8520 gene product; lace1; LACE1_HUMAN; Lactation elevated protein 1; Lactivation elevated 1; Protein AFG1 homolog

Inquire Recombinant Human Lactation elevated protein 1 (LACE1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification